Document:

EXHIBIT
10.13

 

NEITHER THE ISSUANCE AND SALE OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE
TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144
OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

Nano
Vibronix, Inc.

 

Form
of Warrant To Purchase Common Stock

 

Warrant No.: ____-__

Date of Issuance: __________ (“Issuance
Date”)

 

Nano Vibronix, Inc.,
a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, ____________, the registered holder hereof or its permitted assigns (the
“Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise
Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase
Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), at any time or times
after the date hereof, but not after 11:59 p.m., New York time, on _____ __, 20__, ___________ (______) (subject to adjustment
as provided herein) fully paid and nonassessable shares of Common Stock (as defined below) (the “Warrant Shares”).

 

		1.	EXERCISE OF WARRANT.

 

(a)          Mechanics
of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day after the
Issuance Date, in whole or in part, by delivery (whether via facsimile or otherwise) of a written notice, in the form
attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to
exercise this Warrant. Within one (1) Business Day following an exercise of this Warrant as aforesaid, the Holder shall
deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied by
the number of Warrant Shares as to which this Warrant was so exercised (the “Aggregate Exercise
Price”) in the manner set forth in Section 1(c) below. The Holder shall not be required to deliver the original
of this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less
than all of the Warrant Shares shall have the same effect as cancellation of the original of this Warrant and issuance of a
new Warrant evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise
Notice for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original of this
Warrant after delivery of the Warrant Shares in accordance with the terms hereof. On or before the first (1st)
Business Day following the date on which the Company has received an Exercise Notice and payment of the Aggregate Exercise
Price for the number of Warrant Shares for which this Warrant was so exercised, the Company shall transmit by facsimile an
acknowledgment of confirmation of receipt of such Exercise Notice to the Holder and the Company’s transfer agent for
the Warrant Shares, if any. On or before the third (3rd) Business Day following the date on which the Company has
received such Exercise Notice and payment of the Aggregate Exercise Price for the number of Warrant Shares for which
this Warrant was so exercised, the Company shall issue and deliver to the Holder or, at the Holder’s instruction
pursuant to the Exercise Notice, the Holder’s agent or designee, in each case, sent by reputable overnight courier to
the address as specified in the applicable Exercise Notice, a certificate, registered in the Company’s share register
in the name of the Holder or its designee (as indicated in the applicable Exercise Notice), for the number of shares of
Common Stock to which the Holder is entitled pursuant to such exercise. Upon delivery of an Exercise Notice and payment of
the Aggregate Exercise Price for the number of Warrant Shares for which this Warrant was so exercised, the Holder shall be
deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this
Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing such Warrant Shares.

  

    	 

    	 

    

  

(b)          Exercise
Price. For purposes of this Warrant, “Exercise Price” means $0.38 per Warrant Share, subject to
adjustment as provided herein.

 

(c)          Payment
of Exercise Price. The Holder shall pay the Exercise Price (i) in cash in immediately available funds or (ii) through a
“cashless exercise,” in which event the Company shall issue to the Holder the number of Warrant Shares determined
as follows:

 

	 	
        

        X=
	
	 	 	 
	Where	X=	the number of Warrant Shares to be issued to the Holder.
	 	 	 
	 	Y=	the number of Warrant Shares purchasable upon exercise of all of the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being exercised.
	 	 	 
	 	A=	the Exercise Price.
	 	 	 
	 	B=	the Per Share Market Value of one Warrant Share on the Business Day immediately preceding the date of such election.

 

For purposes of Rule
144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless
exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be
deemed to have commenced, on the date this Warrant was originally issued.

 

(d)          Fractional
Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of
this Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section, be issuable upon exercise
of this Warrant, the number of Warrant Shares to be issued will be rounded up to the nearest whole share.

  

    	2

    	 

    

  

(e)          Insufficient
Authorized Shares. From and after the Issuance Date, the Company shall at all times keep reserved for issuance under this
Warrant a number of shares of Common Stock as shall be necessary to satisfy the Company’s obligation to issue shares of
Common Stock hereunder. If, notwithstanding the foregoing, and not in limitation thereof, at any time while this Warrant remains
outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock (an “Authorized
Share Failure”) to satisfy its obligation to reserve for issuance upon exercise of this Warrant (the “Required
Reserve Amount”), then the Company shall promptly take all action necessary to increase the Company’s authorized
shares of Common Stock, as applicable, to an amount sufficient to allow the Company to reserve the Required Reserve Amount. Without
limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share
Failure, but in no event later than ninety (90) days after the occurrence of such Authorized Share Failure, the Company shall
hold a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection
with such meeting, the Company shall provide each stockholder with a proxy statement and shall use its reasonable best efforts
to solicit its stockholders’ approval of such increase in authorized shares of Common Stock, and to cause its board of directors
to recommend to the stockholders that they approve such proposal.

 

		2.	ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT
SHARES.

 

(a)          Stock
Dividends, Subdivisions and Combinations. Without limiting any provision of Section
3, if the Company, at any time after the Issuance Date, (i) pays a stock dividend on one or more classes of its then outstanding
shares of Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock,
(ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its then outstanding
shares of Common Stock into a larger number of shares or (iii) combines (by combination, reverse stock split or otherwise) one
or more classes of its then outstanding shares of Common Stock into a smaller number of shares, then in each such case (A) the
Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event and (B) the number of shares of Common Stock for which this Warrant is exercisable immediately after the occurrence
of any such event shall be adjusted to equal the number of shares of Common Stock which a record holder of the same number of shares
of Common Stock for which this Warrant is exercisable immediately prior to the occurrence of such event would own or be entitled
to receive after the happening of such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and
any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of
such subdivision or combination. If any event requiring an adjustment under this paragraph occurs during the period that an Exercise
Price is used in any calculation hereunder, then in such calculation such Exercise Price shall be adjusted appropriately to reflect
such event.

 

(b)          Issuance
of Additional Shares of Stock. In the event the Company shall at any time following
the Issuance Date issue or sell any share of Common Stock (otherwise than as provided in Section 2(a) hereof or pursuant to Common
Stock Equivalents granted or issued prior to the Issuance Date) (an “Additional Share of Stock”) at a
price per share less than the Exercise Price then in effect, or without consideration (in which case such Additional Shares of
Stock shall be deemed to have been issued at a price per share of $0.001 per share), the Exercise Price then in effect upon each
such issuance shall be decreased to the price equal to the consideration per share paid for such Additional Share of Stock, and
the number of Warrant Shares for which this Warrant is exercisable shall be increased such that the Aggregate Exercise Price payable
hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the Aggregate Exercise Price prior to
such adjustment.

 

(c)          Issuance
or Modification of Common Stock Equivalents. In the event the Company shall, at any
time following the Issuance Date: (i) issue or sell any Common Stock Equivalent with an exercise or conversion price less than
the Exercise Price then in effect, or (ii) modify the conversion or exercise price of any Common Stock Equivalent issued prior
to, on or after the Issuance Date, to an exercise or conversion price less than the Exercise Price then in effect, the Exercise
Price then in effect shall be decreased to the exercise or conversion price of such Common Stock Equivalent, and the number of
Warrant Shares for which this Warrant is exercisable shall be increased such that the Aggregate Exercise Price payable hereunder,
after taking into account the decrease in the Exercise Price, shall be equal to the Aggregate Exercise Price prior to such adjustment.

  

    	3

    	 

    

  

(d)          Certain
Issues Excepted. Anything herein to the contrary notwithstanding, the Issuer shall
not be required to make any adjustment to the Exercise Price pursuant to Sections 2(b) or 2(c) hereof upon (i) securities issued
(other than for cash) in connection with a merger, acquisition, or consolidation, (ii) securities issued pursuant to the exercise
or conversion of Common Stock Equivalents issued prior to the Issuance Date (but such exception shall not affect the obligation
to decrease the Warrant Price if required by Section 2(c)(ii) hereof), (iii) securities issued in connection with bona fide strategic
license agreements or other partnering arrangements so long as such issuances are not for the purpose of raising capital and (iv)
Common Stock issued or options to purchase Common Stock granted, in each case, pursuant to the Company’s stock option plans
and employee stock purchase plans that have been approved for adoption by the Company’s board of directors and stockholders.

 

		3.	FUNDAMENTAL TRANSACTIONS.

 

(a)          Fundamental
Transactions. Prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common Stock
are entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a “Corporate
Event”), the Company shall make appropriate provision to insure that the Holder will thereafter have the right to
receive upon an exercise of this Warrant at any time after the consummation of the applicable Fundamental Transaction but prior
to the Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property) issuable
upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock, securities, cash, assets or any
other property whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled
to receive upon the happening of the applicable Fundamental Transaction had this Warrant been exercised immediately prior to the
applicable Fundamental Transaction (without regard to any limitations on the exercise of this Warrant). Provision made pursuant
to the preceding sentence shall be in a form and substance reasonably satisfactory to the Holder.

 

(b)          Application.
The provisions of this Section 3 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events.

 

4.          NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of the Company’s certificate of incorporation,
the Company’s bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as
may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall
not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price
then in effect and (ii) shall take all such actions as may be reasonably necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.

  

    	4

    	 

    

 

 

5.          WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a
holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company
for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as
the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to
any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance
or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the
Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this
Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors
of the Company. Notwithstanding this Section 5, the Company shall provide the Holder with copies of the same notices and other
information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the stockholders.

 

6.          REISSUANCE
OF WARRANTS.

 

(a)          Transfer
of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company
will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 6(d)), registered as the
Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less
than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section
6(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.

 

(b)          Lost,
Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall
suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder satisfactory
to the Company and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and
deliver to the Holder a new Warrant (in accordance with Section 6(d)) representing the right to purchase the Warrant Shares then
underlying this Warrant.

 

(c)          Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the
Company, for a new Warrant or Warrants (in accordance with Section 6(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion
of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional
shares of Common Stock shall be given.

 

(d)          Issuance
of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to
purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Sections 6(a)
or 6(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the
other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date,
and (iv) shall have the same rights and conditions as this Warrant.

 

7.          NOTICES.
Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant to this Warrant
shall be given or delivered by one party to the other in accordance with the notice provisions of the ______________ Securities
Purchase Agreement by and between the Company and Holder dated ______ __, 20__.

  

    	5

    	 

    

  

8.          NOTICES
OF CERTAIN CORPORATE ACTIONS. The Company shall provide the Holder with prompt written notice of all actions taken pursuant
to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting the generality
of the foregoing, the Company will give written notice to the Holder (i) immediately upon each adjustment of the Exercise Price
and the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s) and
(ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any
dividend or distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C) for
determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that
such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder and
(iii) at least ten (10) Business Days prior to the consummation of any Fundamental Transaction.

 

9.          AMENDMENT
AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any
action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the
written consent of the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.

 

10.         SEVERABILITY.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the
broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect
the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without material
change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties
or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good
faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which
comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

11.          GOVERNING
LAW. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York.

 

12.          REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative
and in addition to all other remedies available under this Warrant at law or in equity (including a decree of specific performance
and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure
by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as
expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such
breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of
this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the
necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information
and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance
with the terms and conditions of this Warrant (including, without limitation, compliance with Section 2 hereof). The issuance of
shares and certificates for shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to the
Holder or such shares for any issuance tax or other costs in respect thereof, provided that the Company shall not be required to
pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name
other than the Holder or its agent on its behalf.

 

    	6

    	 

    

  

13.          TRANSFER.
This Warrant may not be offered for sale, sold, transferred or assigned by the Holder except in a manner consistent with the restrictive
legend on the first page of this Warrant; provided, however, that no such assignment shall relieve the Holder of
its obligations hereunder if such assignee fails to perform such obligations.

 

14.          CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)         “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in the city of New York, New
York are authorized or required by law to remain closed.

 

(b)         “Common
Stock” means the common stock of the Company.

 

(c)         “Common
Stock Equivalent” means any Convertible Security or warrant, Option or other right to subscribe for or purchase any
Additional Shares of Common Stock or any Convertible Security.

 

(d)         “Convertible
Securities” means any stock or other security (other than Options) that is at any time and under any circumstances,
directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire,
any shares of Common Stock.

 

(e)         “Fundamental
Transaction” means that (i) the Company or any of its subsidiaries shall, directly or indirectly, in one or more
related transactions, (1) consolidate or merge with or into (whether or not the Company or any of its subsidiaries is the surviving
corporation) any other Person, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially
all of its respective properties or assets to any other Person, or (3) allow any other Person to make a purchase, tender or exchange
offer that is accepted by the holders of more than 50% of the outstanding shares of Voting Stock of the Company (not including
any shares of Voting Stock of the Company held by the Person or Persons making or party to, or associated or affiliated with the
Persons making or party to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or
other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement)
with any other Person whereby such other Person acquires more than 50% of the outstanding shares of Voting Stock of the Company
(not including any shares of Voting Stock of the Company held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination),
or (5) reorganize, recapitalize or reclassify the Common Stock, or (ii) any “person” or “group” (as these
terms are used for purposes of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and the rules and regulations promulgated thereunder) is or shall become the “beneficial owner”
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented
by issued and outstanding Voting Stock of the Company.

  

    	7

    	 

    

  

(f)         “Per
Share Market Value” means on any particular date (a) the closing sales price per share of the Common Stock on such
date on any registered national securities exchange on which the Common Stock is then listed, or if there is no such closing sales
price on such date, then the closing sales price on such exchange on the date nearest preceding such date, or (b) if the Common
Stock is not then listed on a registered national securities exchange, the closing sales price for a share of Common Stock in the
over-the-counter market, as reported by the OTC Bulletin Board or the OTC Markets Group, Inc. (or similar organization or agency
succeeding to its functions of reporting prices) at the close of business on such date, or (c) if the Common Stock is not then
reported by the OTC Bulletin Board or the OTC Markets Group, Inc. (or similar organization or agency succeeding to its functions
of reporting prices), the fair market value of a share of Common Stock as determined by the Company’s board of directors,
acting in good faith. In determining the fair market value of any shares of Common Stock no consideration shall be given to any
restrictions on transfer of the Common Stock imposed by agreement or by federal or state securities laws, or to the existence or
absence of, or any limitations on, voting rights.

 

(g)         “Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

(h)         “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.

 

(i)         “Voting
Stock” of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof
have the general voting power to elect, or the general power to appoint, at least a majority of the board of directors, managers
or trustees of such Person (irrespective of whether or not at the time capital stock of any other class or classes shall have or
might have voting power by reason of the happening of any contingency).

 

[signature page follows]

 

    	8

    	 

    

 

IN WITNESS WHEREOF,
the Company and the Holder have caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out
above.

 

	 	Nano Vibronix, Inc.
	 	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title:
	 	 	 
	 	holder
	 	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title:

 

    	 

    	 

    

 

EXHIBIT A

 

EXERCISE NOTICE

 

TO BE EXECUTED BY THE REGISTERED HOLDER
TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK

 

Nano
Vibronix, Inc.

 

The undersigned holder
hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”)
of Nano Vibronix, Inc., a Delaware corporation (the “Company”), evidenced by Warrant No. _______ (the
“Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant.

 

1.         Payment of
Exercise Price. The Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
with the terms of the Warrant.

 

2.         Delivery of
Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ Warrant Shares
in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, to the following address:

  

	 	 	 
	 	 	 
	 	 	 
	 	 	 

  

Date: _______________ __, ______

 

	 	 
	   Name of Registered Holder	 
	 	 
	By:	 	 
	 	Name:	 
	 	Title:Exhibit 10.14

 

Nano Vibronix, Inc.

 

2004 Global Share Option Plan

 

Approved November 18, 2004 

 

    	 

    	 

    

 

TABLE OF CONTENTS

 

	1.	PURPOSE OF THE PLAN	3
	 	 	 
	2.	DEFINITIONS	3
	 	 	 
	3.	ADMINISTRATION OF THE PLAN	5
	 	 	 
	4.	DESIGNATION OF PARTICIPANTS	6
	 	 	 
	5.	SHARES RESERVED FOR THE PLAN	6
	 	 	 
	6.	PURCHASE PRICE	7
	 	 	 
	7. 	ADJUSTMENTS	8
	 	 	 
	8.	TERM AND EXERCISE OF OPTIONS	9
	 	 	 
	9.	VESTING OF OPTIONS	10
	 	 	 
	10	PUCHASE FOR INVESTMENT	11
	 	 	 
	11	SHARES SUBJECT TO RIGHT OF FIRST REFUSAL	11
	 	 	 
	12	DIVIDENDS	12
	 	 	 
	13	RESTRICTIONS ON ASSIGNABILITY AND SALE OF OPTIONS	12
	 	 	 
	14	EFFECTIVE DATE AND DURATION OF THE PLAN	12
	 	 	 
	15	AMENDMENTS OR TERMINATION	13
	 	 	 
	16	GOVERNMENT REGULATIONS	13
	 	 	 
	17	CONTINUANCE OF EMPLOYMENT	13
	 	 	 
	18	GOVERNING LAW AND JURISDICTION	13
	 	 	 
	19	TAX CONSEQUENCES	14
	 	 	 
	20	NON-EXCLUSIVITY OF THE PLAN	14
	 	 	 
	21	MULTIPLE AGREEMENTS	14
	 	 	 
	22	RULES PARTICULAR TO SPECIFIC COUNTRIES	14

 

    	2

    	 

    

 

This plan, as amended from time
to time, shall be known as the Nano Vibronix, Inc. 2004 Global Share Option Plan (the “Plan”).

 

		1.	PURPOSE OF THE PLAN

 

The Plan is intended to provide
an incentive to retain, in the employ of the Company (as defined below) and its affiliates, persons of training, experience and
ability; to attract new employees, directors, consultants and service providers; to encourage the sense of proprietorship of such
persons; and to stimulate the active interest of such persons in the development and financial success of the Company by providing
them with opportunities to purchase shares in the Company.

 

		2.	DEFINITIONS

 

For purposes of interpreting
the Plan and related documents (including the Option Agreement and its appendixes), the following definitions shall apply.

 

		2.1	“Board” means the Board of Directors of the Company.

 

		2.2	“Cause” means (i) conviction of any felony involving moral turpitude or affecting
the Company or its affiliates; (ii) any refusal to carry out a reasonable directive of the Company’s Chief Executive Officer,
Board or the Optionee’s direct supervisor, which involves the business of the Company or its affiliates and was capable of
being lawfully performed; (iii) embezzlement of funds of the Company or its affiliates; (iv) any breach of the Optionee’s
fiduciary duties or duties of care of the Company or its affiliates, including without limitation disclosure of confidential information
of the Company or its affiliates; and (v) any conduct (other than conduct in good faith) reasonably determined by the Board to
be materially detrimental to the Company or its affiliates.

 

		2.3	“Chairman” means the Chairman of the Committee.

 

		2.4	“Committee” means a share option compensation committee of the Board, designated
from time to time by the resolution of the Board, which shall consist of no fewer than two members of the Board.

 

		2.5	“Company” means Nano Vibronix, Inc., a Delaware corporation.

 

		2.6	“Date of Grant” means the date of grant of
an Option determined by the Board or the Committee and set forth in the Option Agreement.

 

		2.7	“Employee” means a person who is employed by the Company or any affiliate.

 

		2.8	“Expiration Date” means the date upon which an Option shall expire, as set forth
in Section 8.2 of the Plan.

 

    	3

    	 

    

 

		2.9	“Fair Market Value” means as of any date, the value of a Share determined as
follows:

 

		(i)	If the Shares are listed on any established stock exchange or any national market system, including
without limitation the Tel Aviv Stock Exchange, the NASDAQ National Market System or the NASDAQ SmallCap Market, the Fair Market
Value shall be the last reported sale price for such Shares (or the highest closing bid, if no sales were reported), as quoted
on such exchange or system for the last market trading day prior to the date of determination, as reported in The Wall Street Journal,
or such other source as the Board deems reliable;

 

		(ii)	If the Shares are not listed on any established stock exchange or national market system as mentioned
in sub-section (i) above but the Shares are regularly quoted by one or more recognized securities dealers, the Fair Market Value
shall be the mean between the highest bid and lowest asked prices quoted for the Shares on the last market trading day prior to
the day of determination; or

 

		(iii)	If the Shares are not listed on any established stock exchange or national market system and the
Shares are not regularly quoted by one or more recognized securities dealers as mentioned in sub-sections (i) and (ii) above, the
Fair Market Value thereof shall be determined in good faith by the Board.

 

		2.10	“IPO” means the initial public offering of the Company’s shares.

 

		2.11	“Option” means an option to purchase one or more Shares pursuant to the Plan.

 

		2.12	“Optionee” means a person who receives or holds an Option under the Plan.

 

		2.13	“Option Agreement”means the share
option agreement between the Company and an Optionee that evidences and sets out the terms and conditions of an Option.

 

		2.14	“Plan” means the Company’s 2004 Global Share Option Plan.

 

		2.15	“Purchase Price” means the purchase price
for each Share subject to an Option.

 

		2.16	“Service Provider” means a director, consultant or adviser or other service
provider of the Company or any affiliate, who is not an Employee.

 

		2.17	“Share” means the common stock, $ 0.001 par
value, of the Company. 

 

		2.18	“Successor Company” means any entity which the Company is merged into or acquires
all or substantially all of the Company’s assets.

  

		2.19	“Transaction” means (i) merger, acquisition
or reorganization of the Company with one or more other entities in which the Company is not the surviving entity, (ii) a sale
of all or substantially all of the assets or shares of the Company to another entity.

 

    	4

    	 

    

 

		2.20	“Vested Option” means any Option, which has already been vested according to
the Vesting Dates.

 

		2.21	“Vesting Dates” means, as determined by the Board or the Committee, the date
as of which the Optionee shall be entitled to exercise an Option or part of an Option, as set forth in Section 9 of the Plan.

 

		3.	ADMINISTRATION OF THE PLAN

 

		3.1	The Board shall have the power to administer the Plan. To the extent permitted under applicable
law, the Board may delegate its powers under the Plan, or any part thereof, to the Committee, in which case, any reference to the
Board in the Plan with respect to the rights so delegated shall be construed as reference to the Committee. Notwithstanding the
foregoing, the Board shall automatically have residual authority (i) if no Committee shall be constituted, (ii) with respect to
rights not delegated by the Board to the Committee, or (iii) if such Committee shall cease to operate for any reason whatsoever.

 

		3.2	The Committee, if appointed, shall select one of its members as its Chairman and shall hold its
meetings at such times and places as the Chairman shall determine. The Committee shall keep records of its meetings and shall make
such rules and regulations for the conduct of its business as it shall deem advisable.

 

		3.3	The Board shall have full power and authority (subject to applicable laws): (i) to designate Optionees;
(ii) to determine the terms and provisions of Option Agreements (which need not be identical) including, but not limited to, the
number of Shares to be covered by each Option, the period and the extent to which the Options may be exercised and the nature and
duration of restrictions as to transferability or restrictions constituting substantial risk of forfeiture; (iii) to accelerate
the right of an Optionee to exercise, in whole or in part, any previously granted Option; (iv) to interpret the provisions and
supervise the administration of the Plan; (v) to determine the Fair Market Value of the Shares; (vi) to designate the type of Options
to be granted to an Optionee; (vii) to determine any other matter which is necessary or desirable for, or incidental to, the administration
of the Plan.

 

		3.4	The Board shall have the authority to grant, in its discretion, to the holder of an outstanding
Option, in exchange for the surrender and cancellation of such Option, a new Option having a Purchase Price equal to, lower than
or higher than the Purchase Price of the original Option so surrendered and canceled, and containing such other terms and conditions
as the Board may prescribe in accordance with the provisions of the Plan.

 

    	5

    	 

    

 

		3.5	Subject to the Company’s incorporation documents, all decisions and elections made by the
Board or the Committee pursuant to the provisions of the Plan shall be made by a majority of its members except that no member
of the Board or the Committee shall vote on, or be counted for quorum purposes, with respect to any proposed action of the Board
or the Committee relating to any Option to be granted to that member. All decisions and elections shall be made in accordance with
the provisions of the Company’s incorporation documents, as the same may be in effect from time to time.

 

		3.6	The interpretation and construction by the Board of any provision of the Plan or of any Option
Agreement there under shall be final and conclusive unless otherwise determined by the Board. 

 

		3.7	Subject to the Company’s incorporation documents, applicable
law, and the resolutions of the Company’s Board and/or shareholders, and to all approvals legally
required, each member of the Board or the Committee shall be indemnified and held harmless by the Company against any cost or expense
(including counsel fees) reasonably incurred by him, or any liability (including any sum paid in settlement of a claim with the
approval of the Company) arising out of any act or omission to act in connection with the Plan unless arising out of such member's
own fraud or bad faith. Such indemnification shall be in addition to any rights of indemnification the member may have as a director
or otherwise under the Company's incorporation documents, any agreement, any vote of shareholders or disinterested directors, insurance
policy or otherwise.

 

		4.	ELIGIBLE PARTICIPANTS

 

Only Employees and/or Service
Providers shall be eligible for participation in the Plan. The grant of an Option hereunder shall neither entitle the Optionee
to participate nor disqualify him or her from participating in, any other grant of Options pursuant to the Plan or any other option
or share plan of the Company or any of its affiliates.

 

		5.	SHARES RESERVED FOR THE PLAN

 

		5.1	The Company has reserved Three Hundred Thousand (300,000) authorized but unissued Shares
for the purposes of the Plan, subject to adjustment as set forth in Section 7 below. Any Shares which remain unissued and which
are not subject to outstanding Options at the termination of the Plan shall cease to be reserved for the purpose of the Plan, but
until termination of the Plan the Company shall at all times reserve a sufficient number of Shares to meet the requirements of
the Plan. Should any Option for any reason expire or be canceled prior to its exercise or relinquishment in full, the Share or
Shares subject to such Option may again be subjected to an Option under the Plan or under future plans.

 

		5.2	Each Option granted pursuant to the Plan, shall be evidenced by a written Option Agreement between
the Company and the Optionee, in such form as the Board shall from time to time approve. Each Option Agreement shall state, inter
alia, the number of Shares to which the Option relates, the type of Option granted thereunder, the Vesting Dates, the Purchase
Price per Share and the Expiration Date.

 

    	6

    	 

    

 

		5.3	Until the consummation of an IPO, Shares issued upon exercise of Options, shall be voted by an
irrevocable proxy (the ”Proxy”), such Proxy to be assigned to the person or persons designated by the Board
(the “Proxy Holder”). Subject to the Company’s incorporation documents, applicable
law and to all approvals legally required, the Proxy Holder shall be indemnified and held harmless
by the Company against any cost or expense (including counsel fees) reasonably incurred by him/her, or any liability (including
any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection
with the voting of such Proxy unless arising out of such Proxy Holder's own fraud or bad faith. Such indemnification shall be in
addition to any rights of indemnification the Proxy Holder(s) may have as a director or otherwise under the Company's incorporation
documents, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise.

 

		6.	PURCHASE PRICE

 

		6.1	The Purchase Price of each Share subject to an Option shall be determined by the Board in its sole
and absolute discretion in accordance with applicable law. Each Option Agreement shall set forth the Purchase Price determined
for each Option.

 

		6.2	The Purchase Price shall be payable upon the exercise of an Option in the following acceptable
forms of payment:

 

		(i)	cash, check or wire transfer.

 

		(ii)	at the discretion of the Board, through delivery of Shares (including
other Shares purchased pursuant to the Options being exercised) having a Fair Market Value equal as of the date of exercise to
the Purchase Price of the Shares to be purchased and acquired upon the exercise of the Option, or by a different form of
cashless exercise method through a third party broker as approved by the Board.

 

		(iii)	at the discretion of the Board, any combination of the methods of payment permitted by any paragraph
of this Section 6.2

 

		6.3	The Purchase Price shall be paid in
currency of the primary economic environment of either the Company or the Employee (that is the functional currency of the Company
or the currency in which the Employee is paid), as shall be determined by the Board.

 

    	7

    	 

    

 

		7.	ADJUSTMENTS

 

Upon the occurrence of any of
the following events, Optionees' rights to purchase Shares under the Plan shall be adjusted as hereafter provided:

 

		7.1	In the event of Transaction, (a) the unexercised Options then outstanding under the Plan shall
be ”Assumed or Substituted” (as defined in Section 7.3 below), (b) appropriate adjustments shall be made to the Purchase
Price of each Option so as to reflect such action and (c) all other terms and conditions of the Option Agreements shall remain
unchanged, including but not limited to the vesting schedule, all subject to the determination of the Board, which determination
shall be in their sole discretion and final. The Company shall notify the Optionee of the Transaction in such form and method as
it deems appropriate at least ten (10) days prior to the effective date of such Transaction.

 

		7.2	Notwithstanding the above and subject to all applicable law, the Board
shall have the power and authority to determine that certain Option Agreements shall provide for the acceleration of the
Vesting Dates of outstanding Options so that they vest prior to the Transaction. For avoidance of doubt, no such acceleration shall
occur, unless expressly specified in the Option Agreement or determined by the Board.

 

		7.3	For the purposes of Section 7.1 above, an Option shall be considered “Assumed or Substituted”
if, the Option shall confer the right, subject to such Option’s original vesting schedule and other provisions contained
in the relevant Option Agreement, to purchase or receive, for each Share underlying such Option immediately prior to the Transaction,
the consideration (whether shares, options, cash, or other securities or property) received in the Transaction by the holders of
Shares for each Share held on the effective date of the Transaction (and if such holders were offered a choice of consideration,
the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration
received in the Transaction is not solely shares of common stock (or their equivalent) of the Successor Company or its parent or
subsidiary, the Board may, with the consent of the Successor Company, provide for the consideration to be received upon the exercise
of the Option to be solely shares of common stock (or their equivalent) of the Successor Company or its parent or subsidiary equal
in Fair Market Value to the per Share consideration received by holders of a majority of the outstanding shares in the Transaction;
and provided further that the Board may determine, in its discretion, that in lieu of such assumption or substitution of Options
for options of the Successor Company or its parent or subsidiary, such Options will be substituted for any other type of asset
or property including cash which is fair under the circumstances.

 

		7.4	If the Company is to be voluntarily liquidated or dissolved while unexercised Vested Options remain
outstanding under the Plan, the Company shall notify all unexercised Vested Option holders of such liquidation or dissolution at
least ten (10) days prior to the effective date thereof, and the Option holders shall then have ten (10) days to exercise any unexercised
Vested Option held by them, in accordance with the exercise procedure set forth herein. Upon the expiration of such ten-day period,
all remaining outstanding Options will terminate immediately. For avoidance of doubt all non Vested Options shall terminate upon
such liquidation or dissolution.

 

    	8

    	 

    

 

		7.5	If the outstanding Shares shall at any time be changed or exchanged by declaration of a share dividend
(bonus shares), Share split or reverse Share split, combination or exchange of shares, recapitalization, or any other like event
by or of the Company, and as often as the same shall occur, then the number, class and kind of the Shares subject to the Plan or
subject to any Options theretofore granted, and the Purchase Prices, shall be appropriately and equitably adjusted so as to maintain
the proportionate number of Shares without changing the aggregate Purchase Price; provided, however, that no adjustment shall be
made by reason of the distribution of subscription rights (rights offering) on outstanding Shares. Upon the occurrence of any of
the foregoing, the class and aggregate number of Shares issuable pursuant to the Plan (as set forth in Section 5 hereof), in respect
of which Options have not yet been exercised, shall be appropriately adjusted (all as determined by the Board whose determination
shall be final).

 

		7.6	Anything herein to the contrary notwithstanding, in any transaction approved by the Board or as
otherwise required by the Company’s Certificate of Incorporation in which all of the stockholders of the Company are to sell,
exchange or transfer their Shares (in connection with a Transaction or otherwise), each Optionee shall be obliged to sell, exchange,
or transfer, as the case may be, any Shares purchased under the Plan and held by the Optionee, in accordance with the instructions
issued by the Board in connection with the transaction, whose determination shall be final.

 

		7.7	The Optionee acknowledges that each Optionee’s rights to sell the Shares may be subject to
certain limitations (including a lock-up period), as will be requested by the Company or its underwriters, and the Optionee unconditionally
agrees and accepts any such limitations.

 

		8.	TERM AND EXERCISE OF OPTIONS

 

		8.1	The Board shall determine the form and method of exercising the Options.
Except as otherwise determined by the Board, Options shall be exercised by the Optionee’s written notice to the Company or
to any third party designated by the Company (the “Representative”), in such form and method as may be determined
by the Company, which exercise shall be effective upon receipt of such notice by the Company and/or the Representative and
the payment of the Purchase Price for the number of Shares with respect to which the Option is being exercised, at the Company’s
or the Representative’s principal office. The notice shall specify the number of Shares with respect
to which the Option is being exercised.

 

		8.2	All Options shall expire upon the earlier of: (i) the expiration date set forth in the Option Agreement;
and (ii) termination of Optionee’s employment or service, subject to the provisions of Section 8.5 below.

 

		8.3	Vested Options may be exercised by the Optionee in whole at any time or in part from time to time
prior to the Expiration Date.

 

		8.4	Unless otherwise approved by the Board, a notice of termination
of employment or services shall be deemed to constitute termination of employment or services.

 

    	9

    	 

    

 

		8.5	Notwithstanding anything to the contrary hereinabove and unless otherwise provided in the Optionee’s
Option Agreement, an Option which had vested on or before the date of termination of the Optionee’s employment or service
may be exercised after the date of termination of Optionee’s employment or service for the additional period set forth below
but in no event later than the expiration date set forth in the Option Agreement:

 

		8.5.1	if termination was made without Cause, such Vested Options still in force and unexpired may be
exercised within a period of three (3) months after the date of such termination; or

 

		8.5.2	if termination was the result of death or disability of the Optionee, such Vested Options still
in force and unexpired may be exercised within a period of twelve (12) months after such date of termination.

 

The Board shall have the authority
to provide for longer periods than the three (3) months or twelve (12) months set forth above
for a period not to exceed the period during which the Options by their terms would otherwise have been exercisable.

 

For avoidance of any doubt,
if termination of employment or service is for Cause, any outstanding unexercised Option will immediately terminate, and the Optionee
shall not have any rights in respect of such outstanding Options.

 

		8.6	To avoid doubt, Optionees shall not have any of the rights or privileges of shareholders of the
Company, in respect of any Shares purchasable upon the exercise of an Option, nor shall they be deemed to be a class of shareholders
or creditors of the Company for the purpose of any law, until registration of the Optionee as holder of such Shares in the Company’s
register of shareholders upon exercise of the Option in accordance with the provisions of the Plan.

 

		8.7	Any Option Agreement may contain such other provisions, not inconsistent with the Plan, as the
Board may, from time to time, deem advisable.

 

		9.	VESTING OF OPTIONS

 

		9.1	Subject to the provisions of the Plan, Options shall vest at the Vesting Dates set forth in the
Option Agreement provided that no Option may be exercised after the Expiration Date.

 

		9.2	The vesting of an Option may be subject to such other terms and conditions, not inconsistent with
the Plan, as the Board may deem appropriate. The vesting provisions of individual Options may vary.

 

    	10

    	 

    

 

		10.	PURCHASE FOR
INVESTMENT

 

The Company’s obligation
to issue or allocate Shares upon exercise of an Option granted under the Plan is expressly conditioned upon: (a) the Company’s
completion of any registration or other qualifications of such Shares under all applicable laws, rules and regulations or (b) representations
and undertakings by the Optionee (or his legal representative, heir or legatee, in the event of the Optionee’s death) to
assure that the sale of the Shares complies with any registration exemption requirements which the Company in its sole discretion
shall deem necessary or advisable. Such required representations and undertakings may include representations
and agreements that such Optionee (or his legal representative, heir, or legatee): (a) is purchasing such Shares for investment
and not with any present intention of selling or otherwise disposing thereof; and (b) agrees to have placed upon the face and reverse
of any certificates evidencing such Shares a legend setting forth (i) any representations and undertakings which such Optionee
has given to the Company or a reference thereto and (ii) that, prior to effecting any sale or other disposition of any such Shares,
the Optionee must furnish to the Company an opinion of counsel, satisfactory to the Company, that such sale or disposition will
not violate the applicable laws, rules and regulations of the United States or any other state having jurisdiction over the Company
and the Optionee.

 

		11.	SHARES SUBJECT TO RIGHT OF FIRST REFUSAL

 

		11.1	Notwithstanding anything to the contrary in the incorporation documents of the Company, none of
the Optionees shall have a right of first refusal with respect to any sale of shares in the Company by virtue of Shares issued
upon the exercise of an Option.

 

		11.2	Unless otherwise determined by the Board, until such time as the Company shall complete an IPO,
an Optionee shall not have the right to sell Shares issued upon the exercise of an Option within six (6) months and one day of
the date of exercise of such Option or issuance of such Shares. 

 

Sale of Shares by the Optionee
shall be subject to a right of first refusal as set forth in the incorporation documents of the Company. In the event that the
incorporation documents of the Company do not contain any provision regarding rights of first refusal, then, unless otherwise determined
by the Board, until such time as the Company shall complete an IPO, the sale of Share issuable upon the exercise of an Option shall
be subject to a right of first refusal on the part of the “Repurchaser(s)”.

 

“Repurchaser(s)” means
(i) the Company, if permitted by applicable law, (ii) if the Company is not permitted by applicable law, then any affiliate of
the Company designated by the Board; or (iii) if no affiliate of the Company is designated by the Board, then the Company’s
existing shareholders (save, for avoidance of doubt, for other Optionees who already exercised their Options), pro rata in accordance
with their shareholding.

 

The Optionee shall give a notice
of sale (hereinafter the “Notice”) to the Company in order to offer the Shares to the Repurchaser(s).

 

		11.3	The Notice shall specify the name of each proposed purchaser or other transferee (hereinafter the
“Proposed Transferee”), the number of Shares offered for sale, the price per Share and the payment terms. The Repurchaser(s)
will be entitled for thirty (30) days from the day of receipt of the Notice (hereinafter the “Notice Period”), to purchase
all or part of the offered Shares on a pro rata basis based upon their respective holdings in the Company.

 

    	11

    	 

    

 

		11.4	If by the end of the Notice Period not all of the offered Shares have been purchased by the Repurchaser(s),
the Optionee shall be entitled to sell such Shares at any time during the ninety (90) days following the end of the Notice Period
on terms not more favorable than those set out in the Notice, provided that the Proposed Transferee agrees in writing that the
provisions of this section shall continue to apply to the Shares in the hands of such Proposed Transferee. Any sale of Shares issued
under the Plan by the Optionee that is not made in accordance with the Plan and the Option Agreement shall be null and void.

 

		12.	DIVIDENDS

 

With respect to all Shares (but
excluding, for avoidance of any doubt, any unexercised Options) allocated or issued upon the exercise of Options purchased by the
Optionee and held by the Optionee or by a trustee, as the case may be, the Optionee shall be entitled to receive dividends with
respect to such Shares, subject to the provisions of the Company’s incorporation documents, as
amended from time to time and subject to any applicable taxation on distribution of dividends.

 

		13.	RESTRICTIONS ON ASSIGNABILITY AND SALE OF OPTIONS

 

No
Option or any right with respect thereto, or purchasable thereunder, whether fully paid or not, shall be assignable, transferable,
or given as collateral nor may any right with respect thereto be given to any third party whatsoever, other than by will or by
the laws of descent and distribution or as specifically otherwise allowed under the Plan. During the lifetime of the Optionee,
each and all of such Optionee’s rights to purchase Shares hereunder shall be exercisable only by the Optionee. Any
action made in contradiction to the aforementioned, shall be null and void.

 

		14.	EFFECTIVE DATE AND DURATION OF THE PLAN

 

The Plan shall
be effective as of the day it was adopted by the Board and shall terminate at the end of ten
(10) years from such day of adoption (the “Termination Date”).

 

The Company shall obtain the
approval of the Company’s shareholders for the adoption of this Plan or for any amendment to this Plan, if shareholders’
approval is necessary or desirable to comply with any applicable law including without limitation the U.S. securities law or the
securities laws of other jurisdictions applicable to Options granted to Optionees under this Plan, or if shareholders’ approval
is required by any authority or by any governmental agencies or national securities exchanges including without limitation the
US Securities and Exchange Commission.

 

    	12

    	 

    

 

		15.	AMENDMENTS OR TERMINATION

 

		15.1	The Board may at any time, subject to the provisions of Section 15.2 below and all applicable law,
amend, alter, suspend or terminate the Plan, provided, however, that no amendment, alteration, suspension or termination
of the Plan shall impair the rights of any Optionee, unless mutually agreed otherwise by the Optionee and the Company, which agreement
must be in writing and signed by the Optionee and the Company. Earlier termination of the Plan prior to the Termination Date shall
not affect the Board’s ability to exercise the powers granted to it hereunder with respect to Options granted under the Plan
prior to the date of such earlier termination.

 

		15.2	The Company shall obtain the approval of the Company’s shareholders
for any amendment to this Plan and/or the Appendixes thereto if shareholders’ approval is required under any applicable law
including without limitation the U.S. securities law or the securities laws of other jurisdictions applicable to Options granted
to Optionees under this Plan and/or the Appendixes thereto, or if shareholders’ approval is required by any authority or
by any governmental agencies or national securities exchanges including without limitation the U.S. Securities and Exchange Commission.

 

		16.	GOVERNMENT REGULATIONS

 

The Plan, the granting and exercise
of Options hereunder and the obligation of the Company to sell and deliver Shares under such Options shall be subject to all applicable
laws, rules, regulations, approvals and consents whether of the United States, the State of Israel, or any other state having jurisdiction
over the Company or the Optionees, including the registration of the Shares under the United States Securities Act 1933 or under
the securities act of any applicable jurisdiction, and to such approvals by any governmental agencies or national securities exchanges
as may be required. Nothing herein shall be deemed to require the Company to register the Shares under the securities law of any
jurisdiction.

 

		17.	CONTINUANCE OF EMPLOYMENT 

 

Neither the Plan nor any Option
Agreement shall impose any obligation on the Company or an affiliate to continue any Optionee in its employ or service, and nothing
in the Plan or in any Option granted pursuant hereto shall confer upon any Optionee any right to continue in the employ or service
of the Company or an affiliate thereof or restrict the right of the Company or an affiliate thereof to terminate such employment
or service at any time.

 

		18.	GOVERNING LAW AND JURISDICTION

 

The Plan shall be governed by
and construed and enforced in accordance with the laws of the State of Delaware as applicable to contracts made and to be performed
therein, without giving effect to the principles of conflict of laws. The competent courts of the State of New York shall have
sole jurisdiction in any matters pertaining to the Plan.

 

    	13

    	 

    

 

		19.	TAX CONSEQUENCES

 

Any
tax consequences to any Optionee arising from the grant or exercise of any Option, from the payment for Shares covered thereby
or from any other event or act (of the Company and/or its affiliates, or the Optionee) hereunder shall be borne solely by the Optionee.
The Company and/or its affiliates shall withhold taxes according to the applicable laws, rules, and regulations, including withholding
taxes at source. The Company shall have the right to withhold taxes from any compensation paid to the Optionee by the Company
or its affiliates. Furthermore, the Optionee shall agree to indemnify the Company and/or its affiliates
and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without
limitation, liabilities relating to withholding.

 

The Company shall not be required
to release any Share certificate to an Optionee until all required payments have been fully made.

 

		20.	NON-EXCLUSIVITY OF THE PLAN

 

The adoption of the Plan by the
Board shall not be construed as amending, modifying or rescinding any previously approved incentive arrangements or as creating
any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without
limitation, the granting of options otherwise than under the Plan, and such arrangements may be either applicable generally or
only in specific cases.

 

		21.	MULTIPLE AGREEMENTS

 

The terms of each Option may
differ from other Options granted under the Plan at the same time, or at any other time. The Board may also grant more than one
Option to a given Optionee during the term of the Plan, either in addition to, or in substitution for, one or more Options previously
granted to that Optionee.

 

		22.	RULES PARTICULAR TO SPECIFIC COUNTRIES

 

Notwithstanding
anything herein to the contrary, the terms and conditions of the Plan may be adjusted with respect to Optionees resident in a particular
country by means of an addendum to the Plan in the form of an appendix (the “Appendix”), and to the extent that
the terms and conditions set forth in the Appendix conflict with any provisions of the Plan, the provisions of the Appendix shall
govern with respect to such Optionees. Terms and conditions set forth in the Appendix shall apply only to Options issued to Optionees
under the jurisdiction of the specific country that is the subject of the Appendix and shall not apply to Options issued to any
other Optionee. The adoption of any such Appendix shall be subject to the approval of the Board and, if required, the approval
of the shareholders of the Company.

 

* * *

 

    	14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]